You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

30 June 2022
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
29 June 2022

A list of self-tests that are approved in Australia

29 June 2022
A list of tests approved for inclusion in the Australian Register of Therapeutic Goods (ARTG)
27 June 2022

COVID-19 vaccine batch release information is now available.

22 June 2022
The TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.
10 June 2022

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

27 May 2022

Find information about the supply of COVID-19 rapid antigen self-tests to assist sponsors, manufacturers and consumers. Also includes information about the detection of multiple respiratory targets such as influenza A, influenza B and COVID-19 in a single rapid antigen test format (Combination...

19 May 2022
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
2 May 2022

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

5 April 2022
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us